
### [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144)
**Label:** congenital myasthenic syndromes with glycosylation defect

**Subclasses:** [MONDO:0014542](http://purl.obolibrary.org/obo/MONDO_0014542) (congenital myasthenic syndrome 15), [MONDO:0014543](http://purl.obolibrary.org/obo/MONDO_0014543) (congenital myasthenic syndrome 14), [MONDO:0013883](http://purl.obolibrary.org/obo/MONDO_0013883) (congenital myasthenic syndrome 13), [MONDO:0012518](http://purl.obolibrary.org/obo/MONDO_0012518) (congenital myasthenic syndrome 12), 

**Corr. equiv. classes:** [OMIM:614750](http://purl.obolibrary.org/obo/OMIM_614750), [OMIM:616228](http://purl.obolibrary.org/obo/OMIM_616228), [OMIM:610542](http://purl.obolibrary.org/obo/OMIM_610542), [OMIM:616227](http://purl.obolibrary.org/obo/OMIM_616227), 

**Class expressions from DL-Learner:**

- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0011006](http://purl.obolibrary.org/obo/HP_0011006) (Abnormality of the musculature of the neck) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) 62.50%
- [HP:0000467](http://purl.obolibrary.org/obo/HP_0000467) (Neck muscle weakness) and [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) 62.50%
- [HP:0000464](http://purl.obolibrary.org/obo/HP_0000464) (Abnormality of the neck) and [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0030319](http://purl.obolibrary.org/obo/HP_0030319) (Weakness of facial musculature) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0030319](http://purl.obolibrary.org/obo/HP_0030319) (Weakness of facial musculature) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0011799](http://purl.obolibrary.org/obo/HP_0011799) (Abnormality of facial soft tissue) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0011799](http://purl.obolibrary.org/obo/HP_0011799) (Abnormality of facial soft tissue) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0030319](http://purl.obolibrary.org/obo/HP_0030319) (Weakness of facial musculature) 62.50%
- [HP:0003403](http://purl.obolibrary.org/obo/HP_0003403) (EMG: decremental response of compound muscle action potential to repetitive nerve stimulation) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 62.50%


